Chronic Obstructive Pulmonary Disease (COPD)
Be part of clinical trials. Do something rewarding.
Chronic Obstructive Pulmonary Disease (COPD) is a progressive respiratory illness that can be debilitating, frustrating and devastating. It can impact both your physical and mental health with symptoms getting in the way of everyday life, such as walking the dog or walking up the stairs.
COPD tends to affect individuals who are smokers, or former smokers as well as those with exposure to workplace environments where you breathe in dust or fumes.
With COPD, your airways become inflamed and the air sacs in your lungs are damaged. This causes your airways to become narrower, which makes it harder to breathe in and out. These breathing difficulties can affect many aspects of your daily life.
The signs of a flare-up (exacerbation) are:
- your breathlessness gets worse
- you cough more
- you produce more sputum
- a change in the colour and consistency of your sputum
With an estimated 1.2 million people living with diagnosed COPD, you are not alone.
If you have been diagnosed with COPD, consider joining our clinical trials, and if you choose to participate, you may receive a free health check and medical advice. We can also help you with transport to and from one of our dedicated clinics.
COPD trials include ‘add on therapy’ trials, meaning you can continue to take your own medication alongside any therapy medication.We are currently recruiting at the following locations
- Hexham View
- Lancashire View
- Manchester View
- Merseyside View
- Midlands View
- North Tees View
- Glasgow View
- Thames Valley View
- Cardiff View
All Synexus trials are approved by an independent ethics committee.
Everything you need to know
As one of the largest and most recognised clinical trial organisations in the world, Synexus provides a friendly relaxed environment where you have the opportunity to help others and maybe also yourself. Clinical trials offer an opportunity to help researchers find better treatments for others in the future.
All Synexus studies are approved by an independent ethics committee.